Holders — by stockHoldings — by fund
B Group, Inc.
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0002043476
$213.0M
disclosed book value
19
positions
17.3%
largest position share
Positions, as of 2026-06-30
top 19 of 19 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | INVESCO QQQ TRPUT | 50,000 | $36.8M | 17.3% |
| 2 | ADMAADMA BIOLOGICS INC | 3.3M | $27.3M | 12.8% |
| 3 | PALIPALISADE BIO INC | 11.4M | $23.9M | 11.2% |
| 4 | NRXPNRX PHARMACEUTICALS INC | 4.1M | $16.7M | 7.9% |
| 5 | FTHFAETH THERAPEUTICS INC | 610,169 | $15.3M | 7.2% |
| 6 | TSHATAYSHA GENE THERAPIES INC | 1.8M | $12.3M | 5.8% |
| 7 | PRAXPRAXIS PRECISION MEDICINES I | 33,237 | $11.1M | 5.2% |
| 8 | CLLSCELLECTIS S A | 3.3M | $9.8M | 4.6% |
| 9 | ZLABZAI LAB LTD | 450,646 | $8.6M | 4% |
| 10 | GPCRSTRUCTURE THERAPEUTICS INC | 140,000 | $7.5M | 3.5% |
| 11 | ORKAORUKA THERAPEUTICS INC | 75,000 | $7.1M | 3.4% |
| 12 | IOVAIOVANCE BIOTHERAPEUTICS INC | 1.5M | $6.2M | 2.9% |
| 13 | SYRESPYRE THERAPEUTICS INC | 70,000 | $6.2M | 2.9% |
| 14 | AURAAURA BIOSCIENCES INC | 764,243 | $5.4M | 2.5% |
| 15 | ASMBASSEMBLY BIOSCIENCES INC | 175,706 | $4.8M | 2.3% |
| 16 | DRUGBRIGHT MINDS BIOSCIENCES INC | 67,500 | $4.7M | 2.2% |
| 17 | RAREULTRAGENYX PHARMACEUTICAL IN | 135,000 | $4.5M | 2.1% |
| 18 | SGHTSIGHT SCIENCES INC | 970,000 | $3.7M | 1.7% |
| 19 | FHTXFOGHORN THERAPEUTICS INC | 200,000 | $976,000 | 0.5% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.